Domestic manufacturing, stable supply, and reduced transportation costs! Contract manufacturing of liquid media for regenerative medicine.
In basic research at research institutions, it is important to have a stable supply of high-quality liquid culture media. In particular, the quality of the media significantly affects the experimental results when culturing iPS cells and mesenchymal stem cells. Liquid media manufactured in a GMP-compliant environment is essential for enhancing the reliability of research. Our company offers GMP-compliant liquid media contract manufacturing services, contributing to the improvement of research quality. 【Application Scenarios】 - Culturing iPS cells, mesenchymal stem cells, etc. - Research in the field of regenerative medicine - Cell culture experiments 【Benefits of Implementation】 - Improved experimental accuracy due to high-quality media - Stabilization of research plans through stable supply - Assurance of reliability through GMP compliance
Inquire About This Product
basic information
【Features】 - Manufacturing environment compliant with GMP - Production line capable of handling small quantities and a variety of products - Extensive use of single-use equipment - Strict raw material management - Containers compatible with bottles and single-use bags 【Our Strengths】 We are a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Ltd. By combining Ajinomoto's high-quality amino acid-based culture media raw materials and formulation development technology with Koji Bio's advanced liquid culture media production technology, we provide high-quality liquid culture media.
Price information
Please contact us separately.
Delivery Time
※It will vary depending on the quantity, so please contact us separately.
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（3）
Download All Catalogs
Company information
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.
![[Custom Buffer Implementation Case Study] Biopharmaceuticals and Vaccine Handling Industry](https://image.mono.ipros.com/public/product/image/2087504/IPROS18324525531674400685.jpg?w=280&h=280)
![GMP-compliant [Contract Manufacturing Service for Aseptic Liquids] *Exhibited at Interphex](https://image.mono.ipros.com/public/product/image/2087504/IPROS7399488098711390320.png?w=280&h=280)
![★GMP-compliant [Contract Manufacturing Service for Liquid Media]](https://image.mono.ipros.com/public/product/image/8b5/2000509907/IPROS25255215062239993035.png?w=280&h=280)
